Display options
Share it on

Int J Trichology. 2013 Jan;5(1):47-9. doi: 10.4103/0974-7753.114708.

Alopecia areata treated with phenolisation and intravenous dexamethasone pulses.

International journal of trichology

Sumit Kar, Neha Singh

Affiliations

  1. Department of Dermatology, Venereology and Leprosy, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha, Maharashtra, India.

PMID: 23960401 PMCID: PMC3746231 DOI: 10.4103/0974-7753.114708

Abstract

Phenol is an aromatic hydrocarbon derived from coal tar or manufactured from monochlorobenzene. Alopecia areata is a common non scarring autoimmune condition characterised by patchy loss of hair without atrophy. Various treatment modalities have been proposed and used for the treatment of alopecia areata, which is indeed a difficult condition to treat. Variable results have been documented using intralesional corticosteroid injections, topical minoxidil, topical anthralin ointment, topical contact sensitizers like diphencyprone, dinitrochlorobenzene or squaric acid dibutyl ester, and oral mini pulse with betamethasone. The use of 88% phenol for the treatment of alopecia areata has been documented in literature, but it has failed to secure a place in the priority list. Herein we have reported a case of a young girl who was treated with short-time aggressive therapy using 88% phenol and dexamethasone pulse therapy and who responded well to the treatment with no recurrence in the last 6 months of follow-up.

Keywords: Alopecia areata; chemical peeling; dexamethasone pulses; phenol

References

  1. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1451-3 - PubMed
  2. Indian J Dermatol Venereol Leprol. 1999 Mar-Apr;65(2):93-8 - PubMed
  3. Dermatology. 1993;187(4):282-5 - PubMed
  4. Int J Dermatol. 1996 Feb;35(2):133-6 - PubMed

Publication Types